(Q30359476)

20 June 2017

title

Rationing of influenza vaccine during a pandemic: ethical analyses. (English)

1 reference

20 June 2017

0 references

0 references

1 reference

1

Richard Kent Zimmerman

1 reference

20 June 2017

language of work or name

English

0 references

publication date

30 November 2006

1 reference

20 June 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

20 June 2017

volume

25

1 reference

20 June 2017

issue

11

1 reference

20 June 2017

page(s)

2019-2026

1 reference

Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Emerging infections: pandemic influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Unusual outbreak of influenza A in a Wyoming nursing home

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Impact of influenza A in a nursing home

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Influenza vaccination of healthcare workers and vaccine allocation for healthcare workers during vaccine shortages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Strategies for containing an emerging influenza pandemic in Southeast Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

An influenza simulation model for immunization studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Transmissibility of 1918 pandemic influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Time course of symptom resolution in patients with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Bacterial pneumonia in the elderly: the observations of Sir William Osler in retrospect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Pneumonia: the demented patient's best friend? Discomfort after starting or withholding antibiotic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Impact of epidemic type A influenza in a defined adult population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Prospects for pandemic influenza control with currently available vaccines and antivirals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Avian influenza A (H5N1) infection in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Improvement of inactivated influenza virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Justice, health, and healthcare

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

The nature of procedural preferences for health-care rationing decisions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Medical countermeasures for pandemic influenza: ethics and the law.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

QALYfying the value of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Quality of life and resuscitation decisions in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

The use of quality-of-life considerations in medical decision making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Rationing influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Influenza vaccine scarcity 2004-05: implications for biosecurity and public health preparedness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Strategy for distribution of influenza vaccine to high-risk groups and children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Public communication, risk perception, and the viability of preventive vaccination against communicable diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Vaccine criticism on the World Wide Web.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

Anti-vaccinationists past and present

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.045

10.1016/J.VACCINE.2006.11.045

7 January 2021

Identifiers

DOI

1 reference

20 June 2017

1 reference